Lung cancer is the deadliest form of cancer in the world, and 80 percent of death are related to smoking. In addition to tobacco control, effective chemoprevention strategies are therefore needed. A team of scientists from ...
Oct 3, 2018
0
2
Facing a rising death toll from drug overdoses, state lawmakers across the country are testing a strategy to boost treatment for opioid addicts: Force drug manufacturers and their distributors to pay for it.
Apr 28, 2018
0
2
(HealthDay)—Vagus nerve stimulation may represent a new therapeutic option for patients with Crohn's disease (CD), according to a report published online April 18 in the Journal of Internal Medicine.
May 3, 2017
0
1
Valeant Pharmaceuticals is drawing attention to a potential glaucoma treatment and its focus on product development, as the Canadian drugmaker continues to build its case to investors for a takeover of Botox-maker Allergan.
Sep 25, 2014
0
0
(Medical Xpress)—Sometimes the best solutions are the simplest ones. This is the philosophy that Northeastern professor Vladimir Torchilin and his team took in new research carried out in collaboration with physics professor ...
Jun 2, 2014
1
0
The Supreme Court is wading into a patent dispute between rival pharmaceutical companies over a multiple sclerosis treatment.
Mar 31, 2014
0
0
Despite major advances in the pharmaceutical treatment of disease, many children reject medicines due to an aversion to bitter taste. As such, bitterness presents a key obstacle to the acceptance and effectiveness of beneficial ...
Jul 24, 2013
0
0
A University of Southampton Professor, in collaboration with colleagues at the BC Cancer Agency Research Centre, have discovered a novel way of killing cancer cells. The research, recently published in the journal Cell, has ...
Jul 10, 2013
3
0
Dr. Ethan Basch of UNC calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration ...
Jul 8, 2013
0
0
New potentially life-saving HIV drugs are "beyond reach" due to restrictive patents, Doctors Without Borders (MSF) said Tuesday, even though basic medication for the disease has become cheaper.
Jul 2, 2013
2
0
